Lymphomatoid Papulosis: Diagnosis and Treatment

Lymphomatoid Papulosis (LyP) is a rare skin disorder that involves cancerous looking skin lesions. It is more than a skin condition; it is the mildest of the indolent, cutaneous t-cell lymphomas. These lesions are actually benign (not harmful), although they have T-cells that resemble abnormal tumors in lymphomas. Most patients don’t have lymphoma when they are diagnosed with this conditon; only 20% of patients with lymphomatoid papulosis (LyP) develop more extensive lymphoma at any point in their lifetime (before, during, or after diagnosis).

The incidence of this disease in the United States is 1.9 cases per one million people, so it is extremely rare. Hodgkin’s disease, mycosis fungoides, and large cell lymphoma are associated with the disease for patients who are, in fact, diagnosed with lymphoma.

Diagnosis of Lymphomatoid Papulosis

Patients present with raised bumps on the skin that may develop into blood or pus-filled blisters. These papules (lesions) may become crusty or itchy. They are usually found on the chest, back, stomach, arms or legs. Lesions usually heal on their own within a few weeks of their appearance, and they leave behind no visual scarring.

A diagnosis is made via skin biopsy. The lesions may be type A, type B, or type C, depending on their appearance.

Treatment for Lymphomatoid Papulosis

Since these lesions typically heal on their own, there is no cure for the disease. Some topical treatments have been used in clinical trials, as well as the chemotherapy agent methotrexate. However, these treatments only ease symptoms until the body heals on its own. This can take several years.

Photo: Pexels

lymphoma roundup

More Articles

More Articles

In T cell lymphoma, T lymphocytes, which are an essential part of the body's immune response, become malignant. T cell lymphomas account for about...

In non-Hodgkin's lymphoma, you have your B-cell lymphomas and you have your T-cell lymphomas.

Why B...

MALT lymphoma is a rare B-cell non-Hodgkin's lymphoma that typically runs an indolent or slow-growing clinical...

Mantle cell lymphoma (MCL) is a relatively rare B-cell subtype of non-Hodgkin'...

T-Cell Lymphoblastic Lymphoma (T-LBL) is a very rare subtype of non-Hodgkin's lymphoma. It tends to develop in...

In general, a diagnosis of T-cell lymphoma denotes a poorer prognosis than a diagnosis of B-cell lymphoma. One of...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

After some of the dust has settled, the thoughts of many new lymphoma patients turn to diet and nutrition. They want to know if, in the past,...

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

In a perfect world, every case of cancer would respond to, and be cured by first-line therapy. Unfortunately, it is not often the case. This is...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

In 1964, researchers at the National Cancer Institute developed the first combination chemotherapy that cured a...

CHOP chemotherapy is one of the most common chemotherapy regimens for treating Non-...